VivoSeq
Other

Glycopyrrolate

0

Pipeline Programs↗

2

Active Trials↗

2

Companies Involved↗

Glycopyrrolate is an early-stage landscape with 0 programs across 2 companies. The most active players are Chiesi Farmaceutici S.p.A., Verona Pharma plc.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Chiesi Farmaceutici S.p.A. logo

Chiesi Farmaceutici S.p.A.

0 programs

PreclinicalV

Verona Pharma plc

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

11

clinical trials

Completed8 · 73%
Active, not recruiting1 · 9%
Unknown status1 · 9%
Recruiting1 · 9%

Clinical Trials

Trial Activity

11 trials

A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
Recruiting·VVerona Pharma plc·Phase 2·NCT07016412·480 enrolled
Neostigmine and Glycopyrrolate by Iontophoresis
Active, not recruiting·JJames J. Peters Veterans Affairs Medical Center·Phase 3·NCT06351995·6 enrolled
Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers
Completed·Chiesi Farmaceutici S.p.A. logoChiesi Farmaceutici S.p.A.·Phase 1·NCT01398111·44 enrolled
A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD
Completed·VVerona Pharma plc·Phase 2·NCT06545500·46 enrolled
Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD
Completed·Chiesi Farmaceutici S.p.A. logoChiesi Farmaceutici S.p.A.·Phase 3·NCT01917331·1,368 enrolled
Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®)
Completed·—·N/A·NCT03050242·78 enrolled
Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium
Completed·CCiusss de L'Est de l'Île de Montréal·Phase 4·NCT05718934·144 enrolled
Echocardiographic Study of the Haemodynamic Effects of Remifentanil With and Without Glycopyrrolate in Healthy Children
Completed·UUniversity Hospital, Ghent·Phase 2·NCT00315536·63 enrolled
Pharmacokinetics of Neostigmine and Glycopyrrolate
Completed·JJames J. Peters Veterans Affairs Medical Center·Phase 1·NCT04027972·13 enrolled
Sugammadex v.s. Neostigmine/Glycopyrrolate
Completed·NNational Taiwan University Hospital·N/A·NCT06398899·124 enrolled
Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort
Unknown status·SSeoul National University Hospital·N/A·NCT02228473·76 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)